RxDoctor Payments Data

Melanie Emily, APRN

Family · Belpre, KSNPI 1760988000

Payments from drug & device makers

$765in general payments, 2019–2025

Across 34 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eko Health, Inc.$225
  • Otsuka America Pharmaceutical, Inc.$127
  • AbbVie$82
  • Novo Nordisk$60
  • AstraZeneca$50
  • Amgen$30
  • plus $191 from 11 others

What the payments were for

  • Speaking & faculty fees$22529%
  • Food & beverage$54071%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$765 in reported general payments places this provider in the 65th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$2,802
Medicare patients
61
Services billed
265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban39$39,752
TrulicityDulaglutide22$27,651
Synjardy XrEmpagliflozin/Metformin Hcl22$19,268
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$19,174
OzempicSemaglutide11$15,732
FarxigaDapagliflozin Propanediol11$14,112
JardianceEmpagliflozin14$10,940
ShingrixVaricella-Zoster Ge/As01b/Pf16$3,595
Ventolin HfaAlbuterol Sulfate22$1,300
Albuterol Sulfate HfaAlbuterol Sulfate35$1,137
Potassium Chloride61$891
Gabapentin55$813
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$672
Rosuvastatin Calcium47$557
Simvastatin65$467

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$23$39,75239 claims
Boehringer IngelheimSynjardy Xr, Jardiance$18$30,20836 claims
GSKTrelegy Ellipta, Shingrix$29$22,76937 claims
Novo NordiskOzempic$60$15,73211 claims
AstraZenecaFarxiga$50$14,11211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,579 family providers in Kansas.

Other family in Belpre

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →